Business
UK economy stalls in January as GDP flatlines and Middle East conflict threatens growth
The UK economy unexpectedly stalled at the start of the year, intensifying concerns that escalating geopolitical tensions and rising energy prices could derail growth in 2026.
New figures from the Office for National Statistics (ONS) show that gross domestic product (GDP) recorded no growth in January, following a modest expansion of 0.1 per cent in December. Economists had forecast a stronger start to the year, predicting a monthly increase of around 0.2 per cent.
The latest data suggests that the UK economy entered the year with little momentum, even before the economic impact of the escalating conflict between the United States, Israel and Iran began to filter through global markets.
On a rolling quarterly basis, the economy grew by just 0.2 per cent in the three months to January, only slightly stronger than the 0.1 per cent recorded in the previous quarter and below analysts’ expectations of 0.3 per cent.
The figures reinforce growing fears among economists that the UK’s fragile recovery could stall further as rising oil and gas prices feed through into higher inflation and weaker consumer spending.
Liz McKeown, director of economic statistics at the ONS, said the latest figures highlighted the subdued nature of the recovery.
“The overall picture remains subdued,” she said, noting that several key sectors struggled to gain traction during the month.
The services sector, which accounts for roughly 80 per cent of the UK’s economic output, recorded no growth during January. Production output declined by 0.1 per cent over the same period, while construction activity provided the only positive contribution, rising by 0.2 per cent.
Economists warned that the stagnation in January leaves the economy vulnerable to external shocks, particularly the surge in global energy prices triggered by the widening conflict in the Middle East.
Martin Beck, chief economic adviser at consultancy WPI Strategy, said the disappointing GDP figures showed the economy had already begun losing momentum before geopolitical tensions escalated.
“The UK economy was already losing steam before the latest war-related shock,” he said.
Fergus Jimenez-England, associate economist at the National Institute of Economic and Social Research (NIESR), described the figures as a worrying signal for the months ahead.
“This is a worrying start to the quarter, given that the early-year improvement in business confidence is likely to be short-lived as global disruption linked to the Iran war hits the UK economy,” he said.
Financial markets have already begun adjusting their expectations for monetary policy as energy prices surge. Oil prices have climbed sharply in recent weeks amid fears of prolonged disruption to shipping routes in the Strait of Hormuz, one of the world’s most important oil transit corridors.
Brent crude remained above $100 a barrel on Friday, a level not seen since the energy shocks that followed Russia’s invasion of Ukraine.
The surge in oil and gas prices has complicated the outlook for the Bank of England, which had previously been expected to cut interest rates later this year as inflation gradually eased.
Before the outbreak of the conflict, markets had predicted at least two interest rate reductions in 2026, with investors assigning a roughly 90 per cent probability to a first cut at the Bank’s next meeting. However, rising energy prices have sharply reduced those expectations.
The Bank of England is now widely expected to keep its base rate unchanged at 3.75 per cent when policymakers meet next Thursday, as officials assess whether the energy shock could push inflation higher again.
Although UK inflation fell to 3 per cent in January and is forecast to decline further in the spring, analysts warn that higher energy costs could add as much as one percentage point to inflation later this year depending on how long the conflict persists.
Some economists have warned that household energy bills could rise by as much as £500 in the summer if wholesale gas prices remain elevated.
Government borrowing costs have also risen sharply as investors reassess inflation risks. The yield on benchmark UK government bonds climbed again on Friday, increasing by 0.10 percentage points to 4.78 per cent.
The weaker economic data adds further pressure on Chancellor Rachel Reeves, who has repeatedly emphasised the government’s focus on economic growth while maintaining fiscal discipline.
Responding to the latest GDP figures, Reeves acknowledged the economy faced significant challenges but insisted the government remained committed to strengthening growth.
“I know that there is more to do,” she said. “In an uncertain world we are building a stronger and more secure economy by cutting the cost of living, cutting national debt and creating the conditions for growth to make all parts of the country better off.”
Business groups have also urged ministers to take action to support investment and productivity.
Muniya Barua, deputy chief executive of BusinessLDN, said the latest figures were disappointing following a weak end to 2025.
“After a sluggish end to last year, it’s disappointing to see the economy start the year on the back foot again,” she said.
She warned that geopolitical tensions could undermine both business confidence and consumer spending while pushing inflation higher.
“The war in Iran threatens to hit business and consumer confidence while also pushing up inflation, so it’s vital that the government acts quickly to remove barriers to growth that are within its gift,” Barua added.
She called on ministers to accelerate major infrastructure projects, unlock sites for new housing and review changes to the business rates system that could deter investment.
The latest economic indicators already point to growing strains across the labour market. Unemployment has climbed to its highest level since the pandemic, driven largely by a sharp increase in youth joblessness, which has reached its highest point in more than a decade.
Combined with rising energy costs and slowing economic growth, the data suggests policymakers face a difficult balancing act in the months ahead.
For now, economists say the January figures confirm that the UK economy began 2026 on fragile footing, and that the unfolding geopolitical crisis could make the path to sustained growth even more uncertain.
Amy Ingham
Amy is a newly qualified journalist specialising in business journalism at Business Matters with responsibility for news content for what is now the UK’s largest print and online source of current business news.
Fox News senior medical analyst Dr. Marc Siegel has the latest on the discounted products under President Donald Trump’s plan on ‘The Bottom Line.’
EXCLUSIVE: The White House is expecting to announce an expansion of drugmakers offering discounts on TrumpRx.gov, FOX Business has learned.
As early as today, Amgen and GSK will be added to the list of prescription drug manufacturers offering discounts on the government website. That makes a total of 54 prescription medications from six pharmaceutical companies that have signed on to the most-favored-nation pricing under pressure from President Donald Trump and the threat of tariffs.
Amgen will offer medication on the website that cuts 80% off the retail price. Amjevita has an original price of $1,484, but will be available on TrumpRx.gov for $299. The medication treats rheumatoid arthritis, psoriasis and ulcerative colitis.
FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTHCARE COSTS
President Donald Trump speaks as Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz looks on during an event on drug pricing in the South Court Auditorium on the White House campus Feb. 5, 2026, in Washington, D.C. (Nathan Howard/Getty Images)
The company plans to list Aimovig and Repatha for discounts of 62%.
GSK will discount Incruse at 55% of the retail price. The drug treats COPD and will be listed at $159.
GSK also plans to list Arnuity, Relenza and Anoro at discounts ranging from 10% to 51%.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| AMGN | AMGEN INC. | 366.21 | -1.58 | -0.43% |
| GSK | GSK PLC | 53.39 | -0.89 | -1.64% |
“GSK and Amgen connecting with TrumpRx.gov to offer prescription drugs directly to consumers at most-favored-nations pricing marks another milestone for President Trump’s affordability push,” White House spokesman Kush Desai told FOX Business.
“TrumpRx.gov is just the beginning, however, as Americans are set to (receive) even greater drug pricing discounts, lower insurance premiums and more transparency when Congress passes President Trump’s Great Healthcare Plan.”
Amgen will offer medication on the website that cuts 80% off the retail price. (George Frey/Bloomberg via Getty Images)
The Pharmaceutical Research and Manufacturers of America represents major drug companies.
CEO Stephen Ubl believes “Government-imposed most-favored-nation policies would undermine U.S. competitiveness while doing nothing to address insurance practices that deny care and raise costs for patients.
HOUSE GOP SEEKS OFF-RAMP TO SKY-HIGH HEALTH INSURANCE COSTS FOR MILLIONS OF AMERICANS
“These policies would siphon billions from American R&D, slow the pace of cures and increase reliance on China for future innovation.”
GSK will discount Incruse at 55% of the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)
The White House is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut medical costs.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Under the Biden administration, Bureau of Labor Statistics data shows, prescription drug costs increased 10.4% from January 2021 to January 2025. Under the Trump administration, prescription drug prices increased 0.2% from January 2025 through the latest data from February 2026.
Form 13D/A Health Catalyst For: 13 March
Business
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference – Slideshow
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference – Slideshow
Operator
Greetings, and welcome to Vaxart’s Stockholder Fireside Chat Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the webcast over to David Carey, Finn Partners.
David Carey
Finn Partners, Inc.
Good afternoon, and welcome to today’s call. Joining us from Vaxart are Steve Lo, Chief Executive Officer; Dr. Sean Tucker, Founder and Chief Scientific Officer; Dr. James S. Cummings, Chief Medical Officer; Jeroen Grasman, Chief Financial Officer; and Ed Berg, Senior Vice President and General Counsel.
Before we begin, I would like to remind everyone that during this conference call, Vaxart may make forward-looking statements, including statements about the company’s financial results, financial guidance, its future business strategies and operations, any partnerships with third parties, timing of any anticipated regulatory approvals or that any such approval will be obtained, the company’s future cash runway, ability to regain compliance with NASDAQ listing standards or raise capital if such listing is regained, and its product development and regulatory progress, including statements about its ongoing or planned clinical trials.
Actual results could materially differ from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process and other risks described in the Risk Factors section of Vaxart’s most recently filed annual report on Form 10-K and also on other periodic reports filed with the SEC. Vaxart undertakes no obligation to update
Dan Ives Is Stepping Down as Eightco Chairman
Business
Thomson Reuters Files Documents for Proposed Return of Capital and Share Consolidation Transactions
The transactions consists of a special cash distribution of
The proposed return of capital is intended to distribute cash on a basis that is generally expected to be tax-free for Canadian tax purposes. Shareholders who are taxable in a jurisdiction outside of
Details of the transaction (including information regarding the opt-out right) are described in the management proxy circular and related materials, which are available on thomsonreuters.com in the “Investor Relations” section. The documents were filed with the Canadian securities regulatory authorities on SEDAR+ and are available at www.sedarplus.com. The documents will also be furnished to the
The special meeting of shareholders will be held on
Registered shareholders who have questions or need assistance voting their shares may contact
About
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this news release are forward-looking within the meaning of applicable Canadian and
CONTACTS
MEDIA
+1 647 202 8948
zoe.zanettos@thomsonreuters.com
INVESTORS
Head of Investor Relations
+1 646 540 3249
gary.bisbee@thomsonreuters.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/thomson-reuters-files-documents-for-proposed-return-of-capital-and-share-consolidation-transactions-302713835.html
SOURCE Thomson Reuters
Iridex signs lease for new San Jose headquarters with 90-month term
The search for Nancy Guthrie, the 84-year-old mother of NBC “Today” show co-anchor Savannah Guthrie, entered its 41st day Friday with authorities emphasizing that the February abduction from her Tucson-area home appears to have been targeted, though no suspect has been publicly identified.
Progyny issues notice of settlement for derivative action regarding director pay
Form 4 Better Home & Finance Holding Co For: 13 March
She spent 16 hours a day on Instagram. Jury to decide if Meta is to blame
TrumpRx expands with 2 new drug makers offering prescription discounts
Bitcoin price above $73k as Iran war, oil shock and Fed bets fuel risk-on mood
-
News Videos5 days ago10th Algebra | Financial Planning | Question Bank Solution | Board Exam 2026
-
Tech3 days agoA 1,300-Pound NASA Spacecraft To Re-Enter Earth’s Atmosphere
-
Crypto World4 days agoParadigm, a16z, Winklevoss Capital, Balaji Srinivasan among investors in ZODL
-
Business3 days agoExxonMobil seeks to move corporate registration from New Jersey to Texas
-
Tech3 days agoChatGPT will now generate interactive visuals to help you with math and science concepts
-
Sports6 days agoThree share 2-shot lead entering final round in Hong Kong
-
Sports6 days agoBraveheart Lakshya downs Lai in epic battle to enter All England Open final | Other Sports News
-
Fashion7 hours agoWeekend Open Thread: Addict Lip Glow
-
NewsBeat2 days agoResidents reaction as Shildon murder probe enters second day
-
Entertainment7 days agoHailey Bieber Poses For Sexy Selfies In New Luscious Lip Thirst Traps
-
Business5 days agoSearch for Nancy Guthrie Enters 37th Day as FBI Probes Wi-Fi Jammer Theory
-
Business3 days agoSearch Enters Sixth Week With New Leads in Tucson Abduction Case
-
NewsBeat4 days agoPagazzi Lighting enters administration as 70 jobs lost and 11 stores close across Scotland
-
Tech4 days agoDespite challenges, Ireland sixth in EU for board gender diversity
-
Business4 days agoSearch Enters 39th Day with FBI Tip Line Developments and No Major Breakthroughs
-
NewsBeat2 days agoI Entered The Manosphere. Nothing Could Prepare Me For What I Found.
-
Business7 days agoIran war enters second week as Trump demands ’unconditional surrender’
-
Sports5 days agoSkateboarding World Championships: Britain’s Sky Brown wins park gold
-
Crypto World3 days agoWill Chainlink price reclaim $10 amid volatility squeeze?
-
Sports5 days agoTomorrow’s Top 25 Today: Florida jumps to No. 4; Louisville, Wisconsin enter projected rankings